Stay updated on Pembrolizumab in MPM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MPM Clinical Trial page.

Latest updates to the Pembrolizumab in MPM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study content. This indicates the record is temporarily unavailable or access is restricted, preventing viewing the trial details.SummaryDifference19%

- Check39 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a minor release update to the page.SummaryDifference0.0%

- Check46 days agoChange DetectedThe study's official identifiers now include a funding attribution: 2016 ( U.S. NIH Grant/Contract ). This adds NIH funding as part of the study's identifiers.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a small platform update. It does not affect the study details, enrollment, results, or other content presented on the page.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects a new deployment/build of the page and does not change the study content.SummaryDifference0.0%

- Check96 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, signaling a minor update to the study record metadata without altering study content.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in MPM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MPM Clinical Trial page.